skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mef2c regulates bone mass through Sost-dependent and -independent mechanisms

Journal Article · · Bone
 [1];  [2];  [2];  [2];  [2];  [2];  [3];  [1]
  1. University of California, Merced, CA (United States); Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States); University of California, Davis, CA (United States)
  2. Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
  3. University of California, Davis, CA (United States)

We report Mef2c is a transcription factor that mediates key cellular behaviors that promote endochondral ossification and bone formation. Previously, Mef2c has been shown to regulate Sost transcription via its osteocyte-specific enhancer, ECR5, and conditional deletions of Mef2cfl/fl with either Col1-Cre or Dmp1-Cre produced generalized high bone mass (HBM) consistent with Van Buchem Disease phenotypes. However, Sost-/-; Mef2cfl/fl; Dmp1-Cre mice produced a significantly higher bone mass phenotype that Sost-/- alone suggesting that Mef2c modulates bone mass through additional mechanisms, independent of Sost. To identify new Mef2c transcriptional targets important in bone metabolism, we profiled gene expression by single-cell RNA sequencing in subpopulations of cells isolated from Mef2cfl/fl; Dmp1-Cre and Mef2cfl/fl; Bglap-Cre femurs, both strains exhibiting similar high bone mass phenotypes. However, we found Mef2cfl/fl; Bglap-Cre to also display a growth plate defect characterized by an expansion of several osteoprogenitor subpopulations. Differential gene expression analysis identified a total of 96 up- and 2434 down- regulated genes in Mef2cfl/fl; Bglap-Cre and 176 up- and 1041 down- regulated genes in Mef2cfl/fl; Dmp1-Cre bone cell subpopulations compared to wildtype mice. Mef2c deletion affected the transcriptomes across several cell types including mesenchymal progenitors (MP), osteoprogenitors (OSP), osteoblast (OB), and osteocyte (OCY) subpopulations. Several energy metabolism genes such as Uqcrb, Ndufv2, Ndufs3, Ndufa13, Ndufb9, Ndufb5, Cox6a1, Cox5a, Atp5o, Atp5g2, Atp5b, Atp5 were significantly down regulated in Mef2c-deficient OBs and OCYs, in both strains. Binding motif analysis of promoter regions of differentially expressed genes identified Mef2c binding in Bone Sialoprotein (BSP/Ibsp), a gene known to cause increased trabecular BV/TV in the femurs of Ibsp-/- mice. Immunohistochemical analysis confirmed the absence of Ibsp protein in OBs and OCYs. These findings suggests that the HBM in Sost-/-; Mef2cfl/fl; Dmp1-Cre is caused by a multitude of transcriptional changes in genes that regulate bone formation, two of which are Sost and Ibsp.

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA); National Institutes of Health (NIH)
Grant/Contract Number:
AC52-07NA27344; R56DK110145
OSTI ID:
2315090
Report Number(s):
LLNL-JRNL-845815; 1069320
Journal Information:
Bone, Vol. 179, Issue N/A; ISSN 8756-3282
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (78)

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures journal September 2006
Fracture Prevention with Zoledronate in Older Women with Osteopenia journal December 2018
Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of Its Resorptive Action: Differential Effects of Intermittent and Continuous Administration* journal February 1982
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis journal May 2001
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis journal August 2016
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34) journal June 2017
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody journal June 2010
Electrophoretic studies of human placental dehydrogenases journal August 1967
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis journal June 2018
Myoglobin: an essential hemoprotein in striated muscle journal September 2004
MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease journal January 2008
Synergistic Activation of theN-Methyl-d-aspartate Receptor Subunit 1 Promoter by Myocyte Enhancer Factor 2C and Sp1 journal October 1998
Cabin 1, A Negative Regulator for Calcineurin Signaling in T Lymphocytes journal June 1998
SOX18 Directly Interacts with MEF2C in Endothelial Cells journal September 2001
Sox18 and Sox7 play redundant roles in vascular development journal March 2008
MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development journal March 2007
Targeted deletion of Sost distal enhancer increases bone formation and bone mass journal August 2012
MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS journal January 2021
Hypoxia Activates the PTHrP –MEF2C Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage journal September 2019
Significance of MEF2C and RUNX3 Regulation for Endochondral Differentiation of Human Mesenchymal Progenitor Cells journal March 2020
A ChIP-seq-Defined Genome-Wide Map of MEF2C Binding Reveals Inflammatory Pathways Associated with Its Role in Bone Density Determination journal December 2013
Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women journal November 2014
Mef2c deletion in osteocytes results in increased bone mass journal December 2011
MEF2C Interacts With c-FOS in PTH-Stimulated Mmp13 Gene Expression in Osteoblastic Cells journal July 2017
Dlx5 and Mef2 Regulate a Novel Runx2 Enhancer for Osteoblast-Specific Expression journal April 2014
Global gene expression analysis identifies Mef2c as a potential player in Wnt16-mediated transcriptional regulation journal October 2018
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain journal December 2009
Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues journal January 2004
Control of Mouse Cardiac Morphogenesis and Myogenesis by Transcription Factor MEF2C journal May 1997
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength journal February 2008
Single-cell RNA-Seq reveals changes in immune landscape in post-traumatic osteoarthritis journal July 2022
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer journal May 2020
Integrating single-cell transcriptomic data across different conditions, technologies, and species journal April 2018
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 journal December 2014
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update journal May 2016
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt journal July 2009
CiiiDER: A tool for predicting and analysing transcription factor binding sites journal September 2019
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles journal November 2021
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization journal May 2009
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease journal June 2005
Identification of differentially expressed genes between osteoblasts and osteocytes journal October 2009
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors journal August 2007
Genetic Control of Bone Formation journal November 2009
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation journal May 1997
Osteocytes as Dynamic Multifunctional Cells journal November 2007
Osteocyte: the unrecognized side of bone tissue journal March 2010
In Vivo Osteochondrogenic Potential of Cultured Cells Derived From the Periosteum journal October 1990
Cell energy metabolism and bone formation journal June 2022
Targeting of Mesenchymal Stromal Cells by Cre-Recombinase Transgenes Commonly Used to Target Osteoblast Lineage Cells journal May 2016
Normalizing single-cell RNA sequencing data: challenges and opportunities journal May 2017
Computational and analytical challenges in single-cell transcriptomics journal January 2015
Metabolic regulation of skeletal cell fate and function in physiology and disease journal January 2021
Energy Metabolism in Mesenchymal Stem Cells During Osteogenic Differentiation journal January 2016
Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells journal April 2019
Energy Metabolism During Osteogenic Differentiation: The Role of Akt journal February 2021
NAD(P)H autofluorescence lifetime imaging enables single cell analyses of cellular metabolism of osteoblasts in vitro and in vivo via two-photon microscopy journal January 2022
Glucose metabolism induced by Bmp signaling is essential for murine skeletal development journal November 2018
Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues. journal February 1985
Comparative studies of type X collagen expression in normal and rachitic chicken epiphyseal cartilage. journal October 1989
Domains of type X collagen: alteration of cartilage matrix by fibril association and proteoglycan accumulation. journal May 1992
Hypertrophic Cartilage Matrix journal February 1990
The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage journal January 2005
Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. journal August 1990
Coordinate regulation of collagen and alkaline phosphatase levels in chick embryo chondrocytes. journal October 1985
Role of Type X Collagen on Experimental Mineralization of Eggshell Membranes journal January 1997
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia journal September 1993
Transcriptional regulation of chondrocyte maturation: Potential involvement of transcription factors in OA pathogenesis journal June 2005
Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders journal January 2010
Abnormal Compartmentalization of Cartilage Matrix Components in Mice Lacking Collagen X: Implications for Function journal January 1997
Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover journal March 2019
Deletion of osteopontin or bone sialoprotein induces opposite bone responses to mechanical stimulation in mice journal December 2022
Skeletal Development of Mice Lacking Bone Sialoprotein (BSP) - Impairment of Long Bone Growth and Progressive Establishment of High Trabecular Bone Mass journal May 2014
Mitochondrial Dysfunction and Type 2 Diabetes journal January 2005
Mitochondrial dysfunction and insulin resistance: an update journal March 2015
Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications journal April 2017
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis journal October 2006
Bone, sweet bone—osteoporotic fractures in diabetes mellitus journal January 2012
Deciphering the Relevance of Bone ECM Signaling journal December 2020